Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Seeks Injunction Against Watson Nicotine Gum Labeling

This article was originally published in The Tan Sheet

Executive Summary

SmithKline Beecham Consumer Healthcare alleges copyright infringement of the company's Nicorette smoking cessation gum in a lawsuit filed against Watson Pharmaceuticals and its subsidiaries, Watson Laboratories and Circa Pharmaceuticals, Aug. 26.
Advertisement

Related Content

Hatch/Waxman Act Allows Potential Copyright Infringement - Court
Hatch/Waxman Act Allows Potential Copyright Infringement - Court
SmithKline Smoking Cessation Sales Reach $609 Mil. In 1999
Watson Pharmaceuticals
Watson Seeking FDA Clarification On Nicotine Gum User Guide, Cassette
SmithKline v. Watson
Watson Private Label Nicotine Gum Launching In September
Watson Private Label Nicotine Gum Launching In September
SmithKline Nicorette Mint Spurs Gum Sales 8% In Second Quarter
Circa Pharmaceuticals

Topics

Advertisement
UsernamePublicRestriction

Register

PS090294

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel